People who are suffering under movement disorders such as Parkinson’s disease profit by the possibilities of the central nervous system imaging.
In particular nuclear medicine examinations using SPECT procedures play a substantial role in the differential diagnosis of Parkinson’s disease. With the help of the dopamine transporter SPECT and the dopamine-D2-receptor SPECT a Parkinson’s disease can be separated from atypical and secondary parkinsonian syndromes. The dopamine transporter SPECT shows a pathological reaction in neurodegenerative diseases and for diseases which are going hand in hand without neurodegeneration the transporter shows normal results. The dopamine-D2-receptor SPECT has, however, for Parkinson’s disease a normal enrichment of the used tracer and for atypical parkinsonian syndromes a reduced uptake. Depending on the outcome of the examination a Parkinson’s disease can be excluded or ensured.